Clinical trial
Drug Interactions Between ATOvaquone Used in MAlaria Prophylaxis and Antiretroviral Agents in HIV-1 Infected Patients (ATOMA)
NCT00421473 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Drug Interactions Between ATOvaquone Used in MAlaria Prophylaxis and Antiretroviral Agents in HIV-1 Infected Patients (ATOMA)
- Lead sponsor
- Radboud University Medical Center
- Phase
- Phase 4
- Overall status
- Completed
- Start date
- March 31, 2007
- Completion date
- December 31, 2008
- Enrollment
- 79 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.